Showing results (231-240 of 435) with videos related to
Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Targeting of activated fibroblasts for imaging and therapyThomas Lindner, Anastasia Loktev, Frederik Giesel, et al.EJNMMI Radiopharmacy and Chemistry|October 30, 2019
[11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 yearsCarlotta Taddei, Victor W PikeEJNMMI Radiopharmacy and Chemistry|October 30, 2019
Automated synthesis of [11C]L-glutamine on Synthra HCN plus synthesis modulePrashanth K Padakanti, Shihong Li, Alexander Schmitz, et al.EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Fast and efficient copper-mediated 18F-fluorination of arylstannanes, aryl boronic acids, and aryl boronic esters without azeotropic dryingSalla Orvokki Lahdenpohja, Noora Annika Rajala, Johan Rajander, et al.EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Ethanol effects on 68Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processingMichael Meisenheimer, Stefan Kürpig, Markus Essler, et al.EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical productionChristopher Frank, Georg Winter, Fredrik Rensei, et al.EJNMMI Radiopharmacy and Chemistry|June 13, 2022
Current status on cyclotron facilities and related infrastructure supporting PET applications in Latin America and the CaribbeanMiguel A Avila-Rodriguez, Amir R Jalilian, Aruna Korde, et al.EJNMMI Radiopharmacy and Chemistry|June 13, 2022
Synthesis of a 2-nitroimidazole derivative N-(4-[18F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([18 F]FBNA) as PET radiotracer for imaging tumor hypoxiaArian Pérez Nario, Jenilee Woodfield, Sofia Nascimento Dos Santos, et al.EJNMMI Radiopharmacy and Chemistry|December 21, 2022
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancerConrad Chan, Vanessa Prozzo, Sadaf Aghevlian, et al.EJNMMI Radiopharmacy and Chemistry|November 10, 2023
Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)Amirreza Jalilian, Clemens Decristoforo, Melissa Denecke, et al.Pageof 44